Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation

Immunobiology

Volumn 218, Issue 12, 2013, Pages 1477-1487

  Chen, Qiuyan ^a   Mosovsky, Kara L ^a,b   Ross, A Catharine ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

CD138; CD19; CD40; CD86; Pax 5

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ALPHA GALACTOSYLCERAMIDE; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD19 ANTIGEN; CD1D ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; PEANUT AGGLUTININ; RETINOIC ACID; SYNDECAN 1; TETANUS TOXOID; TRANSCRIPTION FACTOR PAX5;

ACTIVATION INDUCED CYTIDINE DEAMINASE GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BLIMP 1 GENE; CELL SELECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMORAL IMMUNITY; IMMUNOPHENOTYPING; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; IRF 4 GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PAX 5 GENE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SPLEEN WEIGHT;

ACTIVATION INDUCED DEAMINASE; AID; ALL-TRANS-RETINOIC ACID; CD138; CD19; CD40; CD86; GC; GERMINAL CENTER; INTERFERON REGULATORY FACTOR; IRF; PAX-5; RA; TETANUS TOXOID; TT; Α-GALACTOSYLCERAMIDE; ΑGALCER;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD1D; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTIDINE DEAMINASE; FEMALE; GALACTOSYLCERAMIDES; INTERFERON REGULATORY FACTORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, B-CELL; TETANUS TOXOID; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 84885927566     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.05.003     Document Type: Article

References (52)

1. Aiba Y., Kameyama M., Yamazaki T., Tedder T.F., Kurosaki T. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 2008, 111:1497-1503.
2. Allie S.R., Zhang W., Tsai C.Y., Noelle R.J., Usherwood E.J. Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation. J. Immunol. 2013, 190:2178-2187.
3. Baracho G.V., Miletic A.V., Omori S.A., Cato M.H., Rickert R.C. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr. Opin. Immunol. 2011, 23:178-183.
4. Barral P., Eckl-Dorna J., Harwood N.E., De Santo C., Salio M., Illarionov P., Besra G.S., Cerundolo V., Batista F.D. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8345-8350.
5. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008, 224:201-214.
6. Cariappa A., Chase C., Liu H., Russell P., Pillai S. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood 2007, 109:2339-2345.
7. Cerutti A., Puga I., Cols M. Innate control of B cell responses. Trends Immunol. 2011, 32:202-211.
8. Chen Q., Mosovsky K.L., Ross A.C. Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo. Clin. Vaccine Immunol. 2011, 18:1015-1020.
9. Chen Q., Ross A.C. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14142-14149.
10. Chen Q., Ross A.C. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells. Exp. Biol. Med. (Maywood) 2007, 232:488-494.
11. Chen Q., Ross A.C. All-trans-retinoic acid and the glycolipid alpha-galactosylceramide combined reduce breast tumor growth and lung metastasis in a 4T1 murine breast tumor model. Nutr. Cancer 2012, 64:1219-1227.
12. Chen X., Esplin B.L., Garrett K.P., Welner R.S., Webb C.F., Kincade P.W. Retinoids accelerate B lineage lymphoid differentiation. J. Immunol. 2008, 180:138-145.
13. Corgnac S., Perret R., Derre L., Zhang L., Stirnemann K., Zauderer M., Speiser D.E., Mach J.P., Romero P., Donda A. CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses. Cancer Immunol. Immunother. 2013, 62:747-760.
14. DeCicco K.L., Youngdahl J.D., Ross A.C. All-trans-retinoic acid and polyriboinosinic: polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 2001, 104:341-348.
15. Devera T.S., Shah H.B., Lang G.A., Lang M.L. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur. J. Immunol. 2008, 38:1001-1011.
16. DiLillo D.J., Matsushita T., Tedder T.F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 2010, 1183:38-57.
17. Dufour F.D., Silveira P.A., Baxter A.G. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes. J. Immunotoxicol. 2008, 5:249-257.
18. Engedal N., Ertesvag A., Blomhoff H.K. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int. Immunol. 2004, 16:443-453.
19. Ertesvag A., Naderi S., Blomhoff H.K. Regulation of B cell proliferation and differentiation by retinoic acid. Semin. Immunol. 2009, 21:36-41.
20. Godfrey D.I., Rossjohn J. New ways to turn on NKT cells. J. Exp. Med. 2011, 208:1121-1125.
21. Grumont R.J., Gerondakis S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 2000, 191:1281-1292.
22. Hao Z., Duncan G.S., Seagal J., Su Y.W., Hong C., Haight J., Chen N.J., Elia A., Wakeham A., Li W.Y., et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity 2008, 29:615-627.
23. Holmes M.L., Pridans C., Nutt S.L. The regulation of the B-cell gene expression programme by Pax5. Immunol. Cell Biol. 2008, 86:47-53.
24. Huang Y.L., Hung J.T., Cheung S.K., Lee H.Y., Chu K.C., Li S.T., Lin Y.C., Ren C.T., Cheng T.J., Hsu T.L., et al. Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2517-2522.
25. Iclozan C., Antonia S., Chiappori A., Chen D.T., Gabrilovich D. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunol. Immunother. 2013, 62:909-918.
26. Iwata M., Eshima Y., Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 2003, 15:1017-1025.
27. Jain S., Chodisetti S.B., Agrewala J.N. CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells. PLoS ONE 2011, 6:e20651.
28. Johnson K., Calame K. Transcription factors controlling the beginning and end of B-cell differentiation. Curr. Opin. Genet. Dev. 2003, 13:522-528.
29. Jourdan M., Caraux A., Caron G., Robert N., Fiol G., Reme T., Bollore K., Vendrell J.P., Le Gallou S., Mourcin F., et al. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J. Immunol. 2011, 187:3931-3941.
30. Lang G.A., Devera T.S., Lang M.L. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 2008, 111:2158-2162.
31. Lang P., Stolpa J.C., Freiberg B.A., Crawford F., Kappler J., Kupfer A., Cambier J.C. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers. Science 2001, 291:1537-1540.
32. Lin K.I., Angelin-Duclos C., Kuo T.C., Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 2002, 22:4771-4780.
33. Luzina I.G., Atamas S.P., Storrer C.E., daSilva L.C., Kelsoe G., Papadimitriou J.C., Handwerger B.S. Spontaneous formation of germinal centers in autoimmune mice. J. Leukoc. Biol. 2001, 70:578-584.
34. Ma Y., Chen Q., Ross A.C. Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations. J. Immunol. 2005, 174:7961-7969.
35. Mallevaey T., Selvanantham T. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'. Immunology 2012, 136:273-282.
36. Matsuda J.L., Mallevaey T., Scott-Browne J., Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 2008, 20:358-368.
37. Minguet S., Dopfer E.P., Pollmer C., Freudenberg M.A., Galanos C., Reth M., Huber M., Schamel W.W. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Eur. J. Immunol. 2008, 38:2475-2487.
38. Mittrucker H.W., Matsuyama T., Grossman A., Kundig T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S., Mak T.W. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997, 275:540-543.
39. Mora J.R., von Andrian U.H. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin. Immunol. 2009, 21:28-35.
40. Morikawa K., Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 2005, 5:1830-1838.
41. Nutt S.L., Tarlinton D.M. Germinal center B and follicular helper T cells: siblings, cousins or just good friends?. Nat. Immunol. 2011, 12:472-477.
42. Pridans C., Holmes M.L., Polli M., Wettenhall J.M., Dakic A., Corcoran L.M., Smyth G.K., Nutt S.L. Identification of Pax5 target genes in early B cell differentiation. J. Immunol. 2008, 180:1719-1728.
43. Ronchi F., Falcone M. Immune regulation by invariant NKT cells in autoimmunity. Front. Biosci. 2008, 13:4827-4837.
44. Ross A.C., Chen Q., Ma Y. Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam. Horm. 2011, 86:103-126.
45. Sato S., Steeber D.A., Tedder T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11558-11562.
46. Schebesta M., Heavey B., Busslinger M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 2002, 14:216-223.
47. Sciammas R., Shaffer A.L., Schatz J.H., Zhao H., Staudt L.M., Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006, 25:225-236.
48. Suvas S., Singh V., Sahdev S., Vohra H., Agrewala J.N. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 2002, 277:7766-7775.
49. Tedder T.F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 1997, 6:107-118.
50. Tierens A., Delabie J., Michiels L., Vandenberghe P., De Wolf-Peeters C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999, 93:226-234.
51. Wuerffel R., Wang L., Grigera F., Manis J., Selsing E., Perlot T., Alt F.W., Cogne M., Pinaud E., Kenter A.L. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity 2007, 27:711-722.
52. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.